CompoAtlas

Pearl

Natural health product licensed in Canada

Licence holder
E. Excel LLC
NPN or DIN-HM
80027732
Status
Active licence
Licence date
20 October 2011
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Nelumbo nucifera

Source : Graine(s)

35 mgNot calculated
Pteria martensii

Source : Perle

90 mgNot calculated
Panax ginseng

Source : Racine

Extraction ratio : 3:1

Dry plant equivalent : 150 mg

50 mgNot calculated

Non-medicinal ingredients

Gelée Royale, cellulose, Eau purifiée

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Panax ginseng is used inHerbal Medicine to help support cognitive function and reduce mental fatigue in cases of mental stress; Panax ginseng is used in Herbal Medicine to help enhance physical capacity in cases of physical stress.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80027732

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line